{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:44:35Z","timestamp":1781228675879,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25461992"],"award-info":[{"award-number":["25461992"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26461957"],"award-info":[{"award-number":["26461957"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10559"],"award-info":[{"award-number":["17K10559"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1692-3","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T14:36:55Z","timestamp":1542638215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Koji","family":"Takada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-9599","authenticated-orcid":false,"given":"Shinichiro","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaichi","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"issue":"16","key":"1692_CR1","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa020989","volume":"347","author":"U Veronesi","year":"2002","unstructured":"Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227\u201332.","journal-title":"N Engl J Med"},{"issue":"16","key":"1692_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233\u201341.","journal-title":"N Engl J Med"},{"issue":"6","key":"1692_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1053\/hupa.2002.124117","volume":"33","author":"GF Schwartz","year":"2002","unstructured":"Schwartz GF, Giuliano AE, Veronesi U, Consensus Conference C. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia. Hum Pathol. 2002;33(6):579\u201389.","journal-title":"Hum Pathol"},{"issue":"6","key":"1692_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546\u201353.","journal-title":"N Engl J Med"},{"issue":"12","key":"1692_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","volume":"7","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7(12):983\u201390.","journal-title":"Lancet Oncol"},{"key":"1692_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12957-015-0471-3","volume":"13","author":"S Kashiwagi","year":"2015","unstructured":"Kashiwagi S, Onoda N, Asano Y, Kurata K, Noda S, Kawajiri H, Takashima T, Ohsawa M, Kitagawa S, Hirakawa K. Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study. World J Surg Oncol. 2015;13:53.","journal-title":"World J Surg Oncol"},{"issue":"20","key":"1692_CR7","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1200\/JCO.2000.18.20.3480","volume":"18","author":"TM Breslin","year":"2000","unstructured":"Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000;18(20):3480\u20136.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1692_CR8","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, Smith R, Julian T, Miller B, Bear HD, Caldwell CB, Walker AP, Mikkelson WM, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2005;23(12):2694\u2013702.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1692_CR9","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","volume":"14","author":"EA Newman","year":"2007","unstructured":"Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol. 2007;14(10):2946\u201352.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1692_CR10","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1245\/s10434-008-0041-9","volume":"15","author":"C Tausch","year":"2008","unstructured":"Tausch C, Konstantiniuk P, Kugler F, Reitsamer R, Roka S, Postlberger S, Haid A, Austrian Sentinel Node Study G. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol. 2008;15(12):3378\u201383.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1692_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrclinonc.2010.223","volume":"8","author":"L Zitvogel","year":"2011","unstructured":"Zitvogel L, Kepp O, Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol. 2011;8(3):151\u201360.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"1692_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298\u2013306.","journal-title":"Nat Rev Cancer"},{"issue":"6165","key":"1692_CR13","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","volume":"342","author":"J Couzin-Frankel","year":"2013","unstructured":"Couzin-Frankel J. Breakthrough of the year 2013. Cancer immunotherapy. Science. 2013;342(6165):1432\u20133.","journal-title":"Science"},{"issue":"9","key":"1692_CR14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1200\/JCO.2014.58.1967","volume":"33","author":"C Denkert","year":"2015","unstructured":"Denkert C, von Minckwitz G, Brase JC, Sinn BV, Gade S, Kronenwett R, Pfitzner BM, Salat C, Loi S, Schmitt WD, et al. Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. J Clin Oncol. 2015;33(9):983\u201391.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1692_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jso.21237","volume":"99","author":"FL Greene","year":"2009","unstructured":"Greene FL, Sobin LH. A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC. J Surg Oncol. 2009;99(5):269\u201372.","journal-title":"J Surg Oncol"},{"issue":"8","key":"1692_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, Panel M. Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22(8):1736\u201347.","journal-title":"Ann Oncol"},{"key":"1692_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/2193-1801-2-372","volume":"2","author":"S Kashiwagi","year":"2013","unstructured":"Kashiwagi S, Onoda N, Asano Y, Noda S, Kawajiri H, Takashima T, Ohsawa M, Kitagawa S, Hirakawa K. Adjunctive imprint cytology of core needle biopsy specimens improved diagnostic accuracy for breast cancer. Springerplus. 2013;2:372.","journal-title":"Springerplus"},{"issue":"13","key":"1692_CR18","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1200\/JCO.2000.18.13.2560","volume":"18","author":"KM McMasters","year":"2000","unstructured":"McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ, Turk PS, Tate PS, Sardi A, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18(13):2560\u20136.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1692_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cncr.10721","volume":"96","author":"A Lee","year":"2002","unstructured":"Lee A, Krishnamurthy S, Sahin A, Symmans WF, Hunt K, Sneige N. Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer. 2002;96(4):225\u201331.","journal-title":"Cancer"},{"issue":"6","key":"1692_CR20","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s00268-011-1094-7","volume":"35","author":"R Khanna","year":"2011","unstructured":"Khanna R, Bhadani S, Khanna S, Pandey M, Kumar M. Touch imprint cytology evaluation of sentinel lymph node in breast cancer. World J Surg. 2011;35(6):1254\u20139.","journal-title":"World J Surg"},{"issue":"12","key":"1692_CR21","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1200\/JCO.2005.03.3225","volume":"24","author":"G Houvenaeghel","year":"2006","unstructured":"Houvenaeghel G, Nos C, Mignotte H, Classe JM, Giard S, Rouanet P, Lorca FP, Jacquemier J, Bardou VJ, Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le C. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement\u2013Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol. 2006;24(12):1814\u201322.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1692_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jnci\/dji021","volume":"97","author":"D Mauri","year":"2005","unstructured":"Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(3):188\u201394.","journal-title":"J Natl Cancer Inst"},{"key":"1692_CR23","first-page":"CD005002","volume":"2","author":"JS Mieog","year":"2007","unstructured":"Mieog JS, van der Hage JA, van de Velde CJ. Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev. 2007;2:CD005002.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1692_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3892\/ol.2012.801","volume":"4","author":"H Kawajiri","year":"2012","unstructured":"Kawajiri H, Takashima T, Onoda N, Kashiwagi S, Noda S, Ishikawa T, Wakasa K, Hirakawa K. Efficacy and feasibility of neoadjuvant chemotherapy with FEC 100 followed by weekly paclitaxel for operable breast cancer. Oncol Lett. 2012;4(4):612\u20136.","journal-title":"Oncol Lett"},{"issue":"2","key":"1692_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"key":"1692_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12893-015-0102-5","volume":"15","author":"S Kashiwagi","year":"2015","unstructured":"Kashiwagi S, Onoda N, Asano Y, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Hirakawa K. Partial mastectomy using manual blunt dissection (MBD) in early breast cancer. BMC Surg. 2015;15:117.","journal-title":"BMC Surg"},{"key":"1692_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/oxfordjournals.jncimonographs.a003469","volume":"30","author":"N Wolmark","year":"2001","unstructured":"Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2001;30:96\u2013102.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"1692_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26(2):259\u201371.","journal-title":"Ann Oncol"},{"issue":"2","key":"1692_CR29","doi-asserted-by":"publisher","first-page":"e0170634","DOI":"10.1371\/journal.pone.0170634","volume":"12","author":"S Kashiwagi","year":"2017","unstructured":"Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Noda S, Takashima T, Onoda N, Tomita S, Ohsawa M, et al. Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer. PLoS ONE. 2017;12(2):e0170634.","journal-title":"PLoS ONE"},{"issue":"1","key":"1692_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10434-999-0109-1","volume":"6","author":"RK Orr","year":"1999","unstructured":"Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival\u2014a Bayesian meta-analysis. Ann Surg Oncol. 1999;6(1):109\u201316.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"1692_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","volume":"32","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, Benson AB 3rd, Bosserman LD, Burstein HJ, Cody H 3rd, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365\u201383.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1692_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/bjs.5209","volume":"93","author":"Y Xing","year":"2006","unstructured":"Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg. 2006;93(5):539\u201346.","journal-title":"Br J Surg"},{"issue":"5","key":"1692_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.acra.2009.01.026","volume":"16","author":"AM Kelly","year":"2009","unstructured":"Kelly AM, Dwamena B, Cronin P, Carlos RC. Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy\u2014systematic review and meta analysis. Acad Radiol. 2009;16(5):551\u201363.","journal-title":"Acad Radiol"},{"issue":"18","key":"1692_CR34","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1016\/j.ejca.2009.08.001","volume":"45","author":"CH van Deurzen","year":"2009","unstructured":"van Deurzen CH, Vriens BE, Tjan-Heijnen VC, van der Wall E, Albregts M, van Hilligersberg R, Monninkhof EM, van Diest PJ. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer. 2009;45(18):3124\u201330.","journal-title":"Eur J Cancer"},{"issue":"3","key":"1692_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10549-006-9330-9","volume":"102","author":"S Lee","year":"2007","unstructured":"Lee S, Kim EY, Kang SH, Kim SW, Kim SK, Kang KW, Kwon Y, Shin KH, Kang HS, Ro J, et al. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat. 2007;102(3):283\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1692_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/cncr.22540","volume":"109","author":"J Shen","year":"2007","unstructured":"Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer. 2007;109(7):1255\u201363.","journal-title":"Cancer"},{"issue":"3","key":"1692_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejso.2015.11.018","volume":"42","author":"IT Rubio","year":"2016","unstructured":"Rubio IT. Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: work in progress. Eur J Surg Oncol. 2016;42(3):326\u201332.","journal-title":"Eur J Surg Oncol"},{"issue":"14","key":"1692_CR38","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361.","journal-title":"JAMA"},{"issue":"7","key":"1692_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol"},{"issue":"7","key":"1692_CR40","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N, et al. Effect of preoperative chemotherapy on local\u2013regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15(7):2483\u201393.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1692_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00000658-199907000-00011","volume":"230","author":"HM Kuerer","year":"1999","unstructured":"Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230(1):72\u20138.","journal-title":"Ann Surg"},{"issue":"5","key":"1692_CR42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"12","key":"1692_CR43","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/pin.12355","volume":"65","author":"H Ohtani","year":"2015","unstructured":"Ohtani H, Mori-Shiraishi K, Nakajima M, Ueki H. Defining lymphocyte-predominant breast cancer by the proportion of lymphocyte-rich stroma and its significance in routine histopathological diagnosis. Pathol Int. 2015;65(12):644\u201351.","journal-title":"Pathol Int"},{"issue":"10","key":"1692_CR44","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","volume":"2","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Adams S, Disis ML. Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review. JAMA Oncol. 2016;2(10):1354\u201360.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1692_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1075-122X.2004.21280.x","volume":"10","author":"DJ Dabbs","year":"2004","unstructured":"Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J. 2004;10(2):101\u20135.","journal-title":"Breast J"},{"issue":"Suppl 3","key":"1692_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1245\/s10434-010-1253-3","volume":"17","author":"M Yi","year":"2010","unstructured":"Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L. Hunt KK: Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. 2010;17(Suppl 3):343\u201351.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1692_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297\u2013305.","journal-title":"Lancet Oncol"},{"issue":"17","key":"1692_CR48","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1200\/JCO.2008.19.7418","volume":"27","author":"C Coutant","year":"2009","unstructured":"Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchal F, Guillemin F, Seince N, Thomas V, Leveque J, Barranger E, et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol. 2009;27(17):2800\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1692_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4048\/jbc.2017.20.3.217","volume":"20","author":"S Zahoor","year":"2017","unstructured":"Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M. Sentinel lymph node biopsy in breast cancer: a clinical review and update. J Breast Cancer. 2017;20(3):217\u201327.","journal-title":"J Breast Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1692-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:02:22Z","timestamp":1589533342000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1692-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1692-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"18 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"318"}}